Aier Eye Hospital Group saw the highest growth of 0.66% in patent filings in April and 0.99% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.66% and grants by 0.32%. GlobalData’s DataBook provides a comprehensive analysis of Aier Eye Hospital Group‘s patent filings and grants. Buy the databook here.
Aier Eye Hospital Group has been focused on protecting inventions in China(CN) with five publications in Q2 2024
The China(CN) Patent Office dominates the patent filings and grants with nearly 100% filings and 100% grants. The China(CN), and European Patent Office(EPO) patent Office are among the top ten patent offices where Aier Eye Hospital Group is filings its patents. Among the top granted patent authorities, Aier Eye Hospital Group has 100% of its grants in China(CN).
Peking University and Capital Medical University could be the strongest competitors for Aier Eye Hospital Group
In terms of grant share, Aier Eye Hospital Group stands first among its competitors followed by Peking University and Capital Medical University.
Ophthalmic devices related patents lead Aier Eye Hospital Group portfolio
Aier Eye Hospital Group has highest number of patents in ophthalmic devices.
For comprehensive analysis of Aier Eye Hospital Group's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.